Gertrude Mumba-Kaunda
Family · South Bend, INNPI 1093146631
Payments from drug & device makers
Across 53 payments — averaging $35.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$360
- Neurocrine Biosciences, Inc.$280
- Insulet Corporation$258
- AstraZeneca$250
- AbbVie$166
- Jazz Pharmaceuticals Inc.$116
- plus $461 from 17 others
What the payments were for
- Food & beverage$1,891100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $360 |
| Neurocrine Biosciences, Inc. | 3 | $280 |
| Insulet Corporation | 5 | $258 |
| AstraZeneca | 2 | $250 |
| AbbVie | 8 | $166 |
| Jazz Pharmaceuticals Inc. | 1 | $116 |
| Alkermes, Inc. | 6 | $99 |
| Johnson & Johnson | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 1 | $33 |
| Novartis | 2 | $32 |
| Noven Therapeutics, LLC | 2 | $29 |
| Almatica Pharma LLC | 1 | $26 |
| Corium, LLC | 1 | $22 |
| Merck | 1 | $20 |
| Insmed, Inc. | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Dexcom, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Pfizer | 1 | $14 |
| Abbott | 1 | $13 |
| GSK | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,891 in reported general payments places this provider in the 75th percentile of 4,392 family providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 60 | $61,763 |
| OzempicSemaglutide | 33 | $50,234 |
| RybelsusSemaglutide | 30 | $38,806 |
| JanuviaSitagliptin Phosphate | 49 | $29,365 |
| FarxigaDapagliflozin Propanediol | 34 | $24,605 |
| Breo ElliptaFluticasone/Vilanterol | 42 | $20,800 |
| TrulicityDulaglutide | 13 | $18,668 |
| EliquisApixaban | 27 | $16,412 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 26 | $9,726 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 13 | $7,411 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 13 | $6,273 |
| MyrbetriqMirabegron | 14 | $6,224 |
| Arnuity ElliptaFluticasone Furoate | 22 | $6,046 |
| Atorvastatin Calcium | 601 | $4,912 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 24 | $4,102 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKBreo Ellipta, Anoro Ellipta, Arnuity Ellipta | $11 | $33,12077 claims |
| MerckJanuvia | $20 | $29,36549 claims |
| AstraZenecaFarxiga, Symbicort | $250 | $27,35846 claims |
| PfizerEliquis | $14 | $16,41227 claims |
| AbbVieSynthroid | $166 | $69013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,392 family providers in Indiana.
Other family in South Bend
- Caitlin VlaeminckSouth Bend$14K
- Tina SizemoreIndianapolis$888K
- Kathalene Keller RineyEvansville$383K
- Robin AndersonPortage$333K
- Marla MosesIndianapolis$142K
- Justin BrownFort Wayne$142K
- Lacey MatheisEvansville$139K
- Myra SikwataHobart$131K
- Elizabeth JohnsonEvansville$108K
- Beverly MaugerFt Wayne$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.